Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

NCT00305864 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

118

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma

Interventions

RADIATION: 3-Dimensional Conformal Radiation Therapy
DRUG: Motexafin Gadolinium
DRUG: Temozolomide

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]